Mutated nucleophosmin 1 as immunotherapy target in acute myeloid leukemiaDyantha I. van der Lee, Marieke Griffioen, Christiaan Kweekel et al.|Journal of Clinical Investigation|2019Cited by 232
Circulating Preproinsulin Signal Peptide–Specific CD8 T Cells Restricted by the Susceptibility Molecule HLA-A24 Are Expanded at Onset of Type 1 Diabetes and Kill β-CellsDeborah Kronenberg‐Versteeg, Mark Peakman, Robin R. Knight et al.|Diabetes|2012Cited by 114
Allogeneic HLA-A*02–Restricted WT1-Specific T Cells from Mismatched Donors Are Highly Reactive but Show Off-Target PromiscuityWillem J.J. Falkenburg, Inge Jedema, J. Joseph Melenhorst et al.|The Journal of Immunology|2011Cited by 37
Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of <i>ITGB2</i>Margot J. Pont, Marieke Griffioen, Dyantha I. van der Lee et al.|Clinical Cancer Research|2016Cited by 17
An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AMLDyantha I. van der Lee, Marieke Griffioen, Georgia Koutsoumpli et al.|Cancers|2021Cited by 14